Estimation of sensitivity of brain’s gliomas to the influence of temodal in citotoxicityc test

Authors

  • Y. A. Orlov Romodanov Neurosurgery Institute, Kiev, Ukraine
  • V. M. Semenova Romodanov Neurosurgery Institute, Kiev, Ukraine
  • L. P. Staino Romodanov Neurosurgery Institute, Kiev, Ukraine

Keywords:

glial tumors, Temodal, sensitivity, cytotoxic test, suspension cultures

Abstract

The sensitivity of 12 brain’s gliomas to the influence of temodal was stadied on shortterm suspension cultures. Anti-tumor effect of the preparation was estimated using citotoxicityc test after their incubation with temodal. The variation sensivsty of glioma’s tumour cells to the direct influence of different concentration of temodal was detected, therefore in every concrete case, there is a necessity to difine the sensitivity before starting the chemotherapy with temodal.

References

Андриянов Ю.В., Андриянова О.И., Голованов М.В. и др. Влияние импульсных электрических полей и акустических ударных волн на культивируемые клетки / Междунар. симпоз. Биология клетки в культуре // Цитология. — 1999. — Т.41, №3–4. — С.257–258.

Гоц Т.Ю. Вплив цитокінів та дексаметазону на альвеолярні макрофаги людини // Лаб. діагностика. — 2001. — Т.1. — С.15–18.

Желудкова О.Г., Тарасова И.С., Горбатых С.В. и др. Лечение анапластических астроцитом и глиобластом у детей с использованием темодала // Соврем. онкология. — 2002. — Т.4, №2. — С.60–62.

Зозуля Ю.А., Верхоглядова Т.П., Шамаев М.И., Малышева Т.А. Гистобиологические принципы классификации опухолей нервной системы и ее клиническое значение // Укр.нейрохирург. журн. — 2001. — №1. — С.32–41.

Орел Н.Ф. Новые цитостатики в лечении злокачественных опухолей // Под ред. Горбуновой В.А. — М., 1998. — С.25–39.

Орлов Ю.А., Климнюк Г.И., Шаверский А.В. Опыт применения темодала при опухолях головного мозга у детей / Материалы III съезда нейрохирургов Украины. — 2003. — С.98.

Орлов Ю.А., Семенова В.М. Цитостатическое действие темодала на культуру тканей глиальных опухолей / Материалы III съезда нейрохирургов Украины. — 2003. — С.22–23.

Поддубная И.В. Новый век — новые возможности химиотерапии: темодал в лечении злокачественных опухолей // Соврем. онкология. — 2002. — Т.4, №1. — С.12–15.

Шишацкая Е.И., Еремеев А.В., Готельзон И.И. Исследование цитотоксичности полиоксиалканоатов при действии их на культивируемые животные клетки / Междунар. симпоз. Биология клетки в культуре // Цитология. — 2001. — Т.43, №9. — С.904.

Avgtropoulos N.G., Batchelor T.T. New Treatment Strategies for Malignant Gliomas // The Oncologist. — 1999. — V.4, №3. — P.209–224.

Chinot O., Honore S., Dufour H. et al. Safety and efficacy of temozolomid in patients with recurrent anaplastic oligodendrogliomas after standart radiotherapy and chemotherapy // J. Clin. Oncol. — 2001. — V.19. — P.2449–2455.

Fridman H.S., Dolan M.E., Pegg A.E. et al. Activity of temozolomide in the treatment of central nervous system tumor / Cancer Pes. — 1995. — V.55. — P.2853–2857.

Levin V.A., Yung A., Prodos M. et al. Temodal (temozolomide) at first relapse in anaplastic astrocytoma patients // J. Neurooncol. — 1997. — V.35 (suppl. 1). — P.185.

Newlandas E.S., Blackledge G.R., Slack J.A. et al. Phase I trial temozolomide // Br. J. Cancer. — 1992. — V.65. — P.287–291.

Stevens M.F.G., Hickman J.A., Langdon S.P. et al. Antitumor activity and pharmacokinetics in mice of 8-carbonyl–3-methyl-imidoso [5,1-d]- 1,2,3,5-tetrazin–4 (3H)-one (CCPG 81045$ M&B 39831), a novel drug with potential as an alternative dacarbasine // Cancer Res. — 1987. — V.47. — P.5846–5852.

Stupp R., Dietrich P. et al. Promising survival for patients with newly diagnosed glioblastoma multiform treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide // J. Clin. Oncjl. — 2002. — V.20. — P.1375–1382.

Wilson A.P., Neal F.E. / Культура животных клеток. Методы / Под ред. Р.Фрешни. — М.: Мир, 1989. — С.256–303.

Yung A., Prodos M., Yaya-Tur R. et al. Temodal at first relapse in anaplastic astrocytoma patients // J. Clin. Oncol. — 1999. — V.17, №9 — Р.2762–2771.

Yung A., Albright R.E., Olson J. A phase II stady of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse // Brit. J. Cancer. — 2000. — V.83, №5. — P.588–593.

Downloads

How to Cite

Orlov, Y. A., Semenova, V. M., & Staino, L. P. Estimation of sensitivity of brain’s gliomas to the influence of temodal in citotoxicityc test. Ukrainian Neurosurgical Journal, (2), 50–54. Retrieved from https://theunj.org/article/view/141700

Issue

No. 2 (2004)

Section

Original articles

License

Copyright (c) 2004 Y. A. Orlov, V. M. Semenova, L. P. Staino

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Ukrainian Neurosurgical Journal abides by the  CREATIVE COMMONS copyright rights and permissions for open access journals.

Authors, who are published in this Journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.

2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.